New imaging science for diabetes research at EASD 2023

Antaros Medical will be presenting lots of new science alongside our collaborators at the 59th European Association for the Study of Diabetes (EASD) Annual Meeting. This year’s meeting is being held in Hamburg, Germany and virtually from October 2-6, 2023.

We will be kept busy during the congress, with a symposium presentation, 4 oral presentations, and a short oral discussion. Please find the abstract details below, and you can access the entire abstract book here.

Title: Novel insights from nuclear imaging techniques
Presenter: Johansson L
Session: S50 – Image-in’ what non-invasive techniques can do for diabetes research and care!
Symposium presentation Thursday, October 5, 9:30-10:00 CEST

Title: Decreased cerebral glucose and increased cerebral fatty acid utilisation during fasting in type 2 diabetes
Abstract number: 68
Authors: Schain M, Johansson E, Laitinen I, Frödén Löwenmark A, Lubberink M, Gummesson A, Nuutila P, Esterline R, Oscarsson J, Johansson L, Heurling K
Session: OP 12 – Diabetes and the brain
Oral presentation Tuesday, October 3 15:30-15:45 CEST

Title: Whole-body measurement of fatty acid uptake in fasting and postprandial conditions
Abstract number: 207
Authors: Laitinen I, Ekström S, Haraldsson H, Pierrou S, Kalliokoski K, Kiugel M, Scheinin M, Southekal S, Lu M, Coskun T, Milicevic Z, Johansson L, Nuutila P
Session: OP 35 – Omics and more: unbiased approaches to tackle obesity
Oral presentation Thursday, October 5 11:15-11:30 CEST

Title: Efficacy and safety of a functionally selective insulin: a 26-week randomised, double blind trial versus insulin glargine in people with type 2 diabetes (T2D)
Abstract number: 11
Authors: Heise T, Haraldsson H, Herbrand T, Johansson L, Jordan J, Nishimura E, Plum-Mörschel L, Tank J, Thórisdóttir Ó, Lyby K
Session: OP 2 – Present, future and future future of insulin therapy
Oral presentation Tuesday, October 3, 11:30-11:45 CEST

Title: SGLT2 inhibitor dapagliflozin enhances skeletal muscle fatty acid uptake in subjects with type 2 diabetes: a positron emission tomography study
Abstract number: 133
Authors: Latva-Rasku A, Tuisku J, Bhowmik A, Keskinen H, Rebelos E, Laurila S, Koffert J, Nummenmaa L, Heurling K, Oscarsson J, Nuutila P
Session: OP 23 – More news from SGLT2s
Oral presentation Wednesday, October 4 15:30-15:45 CEST

Title: A pilot study using [18F] FDG PET/MRI to investigate dual GLP-1 and glucagon receptor agonism on myocardial glucose uptake and myocardial function in adults with type 2 diabetes
Abstract number: 646
Authors: Goodman JDH, Schain M, Lupson V, Horn T, Manavaki R, Fryer TD, Di Stefano G, Amiss E, Jalaludeen N, Haraldsson H, Jermutus L, Cgeriyan J, Johansson L, Ambery P, Wilkinson IB
Session: SO 45 – Dual agonism: two of us
Short oral discussion Wednesday, October 4 12:45-13:45 CEST

Share on Linkedin Share on Twitter